Article Text

Download PDFPDF
Ovarian cancer in the proteomics era
  1. C. M. Annunziata*,
  2. N. Azad*,
  3. A. S. Dhamoon,
  4. G. Whiteley and
  5. E. C. Kohn*,
  1. * Medical Oncology Branch and
  2. Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
  1. Address correspondence and reprint requests to: Christina M. Annunziata, MD, PhD, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10, Room 12N226, 10 Center Drive, Bethesda, MD 20892-1906. Email: annunzic{at}


Ovarian cancer presents a diagnostic challenge because of its subtle clinical presentation and elusive cell of origin. Two new technologies of proteomics have advanced the dissection of the underlying molecular signaling events and the proteomic characterization of ovarian cancer: mass spectrometry and protein array analysis. Mass spectrometry can provide a snapshot of a proteome in time and space, with sensitivity and resolution that may allow identification of the elusive “needle in the haystack” heralding ovarian cancer. Proteomic profiling of tumor tissue samples can survey molecular targets during treatment and quantify changes using reverse phase protein arrays generated from tumor samples captured by microdissection, lysed and spotted in serial dilutions for high-throughput analysis. This approach can be applied to identify the optimal biological dose of a targeted agent and to validate target to outcome link. The evolution of proteomic technologies has the capacity to advance rapidly our understanding of ovarian cancer at a molecular level and thus elucidate new directions for the treatment of this disease

  • mass spectrometry
  • ovarian cancer
  • proteomics
  • tissue microarray

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.